Huma
PrivateLast Round
Early Funding
Sep 13, 2024
Est. Valuation
$1B
Total Funding Raised
$335M
Company Overview
Huma operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Early Funding round in September 2024.
Huma is a healthcare technology company that provides a digital-first platform for remote patient monitoring, decentralized clinical trials, and AI-driven healthcare workflows.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Telemedicine, Medical AI, Patient Engagement, Health IoT
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Huma Comparables
Compare Huma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biofourmis | 85% | |
| Doccla | 79% | |
| Current Health | 78% |
For institutional investors. Book with your work email.
Huma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 13, 2024 | ||||
| Series D | Jul 16, 2024 | ||||
| Strategic | Mar 23, 2022 | ||||
| Series C | May 11, 2021 | ||||
| M&A | Apr 16, 2020 | ||||
Series B | Nov 5, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Huma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stellar Development Foundation | Early Funding |
| Sony Ventures Corporation | Series C |
| Dale Ventures | Seed |
| HV Fund | Series C, Series D |
| NWS Holdings | Series B, Series A |
| Distributed Global | Early Funding |
| Samsung NEXT Ventures | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2025
Launched Hi Scribe, a generative AI clinical documentation tool.
- May 19, 2025
Acquired Aluna to expand US presence.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardOct 23, 2026
Huma receives the Most Transformative Healthtech Company Award for its AI operating system for regulated healthcare.
- invests_intoSep 23, 2026
On Sep 23rd '26, Huma invests $13.8M into ViferaXS GmbH in a Series A financing led with SPRIND and joined by private investors to advance CLLTAXS01 into Phase II in CLL and support Phase I programs.
For institutional investors. Book with your work email.
Huma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Huma's valuation, stock price, and market status.
Is Huma a public or private company?
Huma is a private company.
What is the current stock price of Huma?
Huma is a private company, so its shares have no public market price. Caplight tracks Huma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Huma worth (valuation)?
Huma's valuation is estimated at $1.0B based on funding round data.
Can I buy Huma stock?
Huma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Huma's last funding round?
Huma's most recent funding round was Early Funding on September 13, 2024.
Who are the main investors in Huma?
Key investors in Huma include Dale Ventures, HV Fund, NWS Holdings, Distributed Global, Leaps by Bayer.
Will Huma IPO soon?
No public IPO plans have been announced for Huma.
How can I track Huma secondary market activity?
Caplight tracks bids, offers, and trades in Huma's shares on secondary markets.